Improvement of the Operative Outcome in Patients With Primary VEGF + Unifocal Breast Cancer or DCIS Through the Intraoperative Visualization of the Tumor Using Molecular Imaging and Bevacizumab-IRDye-800CW
Condition: Breast Cancer Intervention: Drug: Bevacizumab-IRDye800CW Sponsor: Technische Universität München Withdrawn
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Breast Cancer | Cancer | Cancer & Oncology | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Research